🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 14 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 24/01/2022 | 199,40 | 202,96 | 195,06 | 202,15 | +1,04% | 3,96% | 580.700 |
| 21/01/2022 | 198,89 | 203,19 | 197,31 | 200,06 | +0,05% | 2,96% | 424.700 |
| 20/01/2022 | 205,24 | 207,70 | 199,71 | 199,97 | -2,49% | 3,89% | 438.300 |
| 19/01/2022 | 213,66 | 213,66 | 205,00 | 205,07 | -3,28% | 4,05% | 325.600 |
| 18/01/2022 | 213,89 | 217,84 | 211,14 | 212,03 | -0,90% | 3,13% | 734.500 |
| 14/01/2022 | 208,40 | 214,03 | 206,73 | 213,96 | +2,87% | 3,50% | 340.700 |
| 13/01/2022 | 206,19 | 210,86 | 204,53 | 208,00 | +0,88% | 3,07% | 357.300 |
| 12/01/2022 | 206,16 | 207,56 | 203,00 | 206,19 | -0,03% | 2,21% | 264.700 |
| 11/01/2022 | 204,27 | 211,22 | 204,27 | 206,25 | +3,52% | 3,40% | 571.200 |
| 10/01/2022 | 198,36 | 199,80 | 195,09 | 199,24 | +0,15% | 2,37% | 740.400 |
| 07/01/2022 | 195,20 | 200,77 | 195,06 | 198,94 | +1,46% | 2,93% | 555.900 |
| 06/01/2022 | 192,15 | 198,48 | 189,86 | 196,07 | +1,65% | 4,49% | 399.200 |
| 05/01/2022 | 199,00 | 200,73 | 192,74 | 192,89 | -3,11% | 4,02% | 487.200 |
| 04/01/2022 | 210,65 | 210,66 | 199,06 | 199,08 | -5,48% | 5,51% | 391.200 |
| 03/01/2022 | 215,57 | 215,57 | 208,37 | 210,63 | -2,52% | 3,34% | 431.300 |
| 31/12/2021 | 215,98 | 218,38 | 215,33 | 216,08 | +0,42% | 1,41% | 192.200 |
| 30/12/2021 | 215,33 | 217,99 | 213,55 | 215,18 | +0,07% | 2,06% | 302.700 |
| 29/12/2021 | 212,49 | 215,97 | 210,92 | 215,02 | +0,57% | 2,38% | 225.800 |
| 28/12/2021 | 215,66 | 217,75 | 213,17 | 213,81 | -0,41% | 2,12% | 172.500 |
| 27/12/2021 | 213,31 | 215,09 | 211,97 | 214,69 | +0,30% | 1,46% | 264.800 |
| 23/12/2021 | 211,40 | 215,85 | 206,80 | 214,04 | +2,04% | 4,28% | 284.300 |
| 22/12/2021 | 202,44 | 210,28 | 202,06 | 209,77 | +2,27% | 4,06% | 361.000 |
| 21/12/2021 | 203,40 | 206,59 | 202,15 | 205,12 | +1,43% | 2,18% | 519.000 |
| 20/12/2021 | 195,36 | 202,32 | 193,67 | 202,22 | +3,14% | 4,43% | 532.700 |
| 17/12/2021 | 194,43 | 198,07 | 192,43 | 196,06 | +0,10% | 2,90% | 686.500 |
| 16/12/2021 | 195,46 | 197,66 | 193,62 | 195,86 | +0,12% | 2,07% | 264.400 |
| 15/12/2021 | 193,60 | 196,56 | 191,09 | 195,62 | +0,87% | 2,83% | 335.900 |
| 14/12/2021 | 190,88 | 195,12 | 190,55 | 193,93 | +1,42% | 2,39% | 518.000 |
| 13/12/2021 | 187,25 | 192,13 | 185,95 | 191,21 | +1,40% | 3,30% | 208.600 |
| 10/12/2021 | 187,50 | 189,53 | 185,48 | 188,57 | +0,82% | 2,16% | 200.500 |